New perspectives in diabetic neuropathy
Neuron · 2023-09 · 111 (17) · 2623-2641
DOI: 10.1016/j.neuron.2023.05.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuron, 2023-09. Verfasst von Stephanie A Eid und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA; NeuroNetwork for Emerging Therapies, University of Michigan, Ann Arbor, MI…. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Diabetes Mellitus, Type 2, Hyperglycemia, Dyslipidemias. Die Arbeit wurde bisher 276-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Wellcome Trust, Medical Research Council.
Abstract (Originalsprache)
Diabetes prevalence continues to climb with the aging population. Type 2 diabetes (T2D), which constitutes most cases, is metabolically acquired. Diabetic peripheral neuropathy (DPN), the most common microvascular complication, is length-dependent damage to peripheral nerves. DPN pathogenesis is complex, but, at its core, it can be viewed as a state of impaired metabolism and bioenergetics failure operating against the backdrop of long peripheral nerve axons supported by glia. This unique peripheral nerve anatomy and the injury consequent to T2D underpins the distal-to-proximal symptomatology of DPN. Earlier work focused on the impact of hyperglycemia on nerve damage and bioenergetics failure, but recent evidence additionally implicates contributions from obesity and dyslipidemia. This review will cover peripheral nerve anatomy, bioenergetics, and glia-axon interactions, building the framework for understanding how hyperglycemia and dyslipidemia induce bioenergetics failure in DPN. DPN and painful DPN still lack disease-modifying therapies, and research on novel mechanism-based approaches is also covered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA; NeuroNetwork for Emerging Therapies, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Neurology, Columbia University, New York, NY 10032, USA.
- Department of Neurology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA; Neuroscience Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.
- Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford OX3 9DU, UK.
- Department of Biomedical Sciences, University of North Dakota, Grand Forks, ND 58202, USA.
- Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA; NeuroNetwork for Emerging Therapies, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: efeldman@umich.edu.
Förderung
- NIDDK NIH HHS
- Wellcome Trust
- Medical Research Council
- NINDS NIH HHS
Zitieren
APA
Eid, S. A., Rumora, A. E., Beirowski, B., Bennett, D. L., Hur, J., Savelieff, M. G., & Feldman, E. L. (2023). New perspectives in diabetic neuropathy. Neuron, 111(17), 2623-2641. https://doi.org/10.1016/j.neuron.2023.05.003
Vancouver
Eid SA, Rumora AE, Beirowski B, Bennett DL, Hur J, Savelieff MG, et al. New perspectives in diabetic neuropathy. Neuron. 2023;111(17):2623-2641. doi:10.1016/j.neuron.2023.05.003
BibTeX
@article{Eid2023,
author = {Eid, Stephanie A and Rumora, Amy E and Beirowski, Bogdan and Bennett, David L and Hur, Junguk and Savelieff, Masha G and Feldman, Eva L},
title = {New perspectives in diabetic neuropathy},
journal = {Neuron},
year = {2023},
volume = {111},
number = {17},
pages = {2623--2641},
doi = {10.1016/j.neuron.2023.05.003}
}
EUVIMED